WallStSmart
NCEL

NewcelX Ltd.

NASDAQ: NCEL · HEALTHCARE · BIOTECHNOLOGY

$3.33
-6.98% today

Updated 2026-06-05

Market cap
$18.74M
P/E ratio
P/S ratio
EPS (TTM)
$-2.16
Dividend yield
52W range
$2 – $31
Volume
0.1M

NewcelX Ltd. (NCEL) Financial statements

SEC filings — annual and quarterly data.

Balance sheet — annual

Item201720182019202020212022202320242025
Total assets$2.29M$145635.00$696429.00$1.21M$5.76M$9.28M$1.85M$2.23M$11.45M
Cash & equivalents$2.18M$6678.00$220267.00$93710.00$5.43M$8.95M$897680.00$1.67M$2.20M
Current assets$2.27M$90163.00$381746.00$196711.00$5.72M$9.25M$1.82M$2.23M$3.18M
Total liabilities$10.01M$8.96M$6.87M$10.20M$5.22M$6.00M$10.68M$826764.00$4.20M
Current liabilities$989955.00$2.41M$4.04M$7.20M$2.40M$3.36M$7.92M$826764.00$4.20M
Long-term debt$0.00$834000.00
Shareholder equity$-7.72M$-8.81M$-6.17M$-8.98M$542388.00$3.28M$-8.83M$1.41M$7.25M
Retained earnings$-16.30M$-21.45M$-26.90M$-29.76M$-41.71M$-58.20M$-70.37M$-74.43M$-84.89M
Accounts receivable$36893.00$75388.00$61207.00$38551.00$41243.00$10664.00$400000.00
Inventory$-9356.00$-61206.00$-38551.00$-41243.00
Goodwill$1.73M

Frequently asked questions

How much free cash flow does NCEL generate?

NCEL produced $-2.77M in free cash flow in its most recent fiscal year. Free cash flow is what is left after running and reinvesting in the business, and it is the cash that actually funds buybacks, dividends, and a stronger balance sheet.

Is NCEL's balance sheet healthy?

NCEL holds $2.20M in cash and equivalents against — in long-term debt, on $7.25M of shareholder equity. That debt is best read against the cash flow the business throws off each year.